{"url_path":"/sec/crvo/8-k/2026-06-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-021309-index.html","accession_number":"0001437749-26-021309","cik":"0001053691","ticker":"CRVO","issuer_name":"CervoMed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-021309-index.html","primary_entity_key":"0001053691","primary_entity_name":"CervoMed Inc."},"word_count":79,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n**(d) Exhibits**\n\n \n\n**Exhibit **\n\n**No.**\n\n \n\n**Description**\n\n \n\n \n\n \n\n99.1\n\n \n\n[Press Release.](ex_979559.htm)\n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n3\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**CervoMed Inc.**\n\n \n\n \n\n \n\n \n\n \n\n \n\nDate: June 22, 2026\n\nBy:\n\n/s/ William Elder\n\n \n\n \n\n \n\nName:\n\nWilliam Elder\n\n \n\n \n\n \n\nTitle:\n\nChief Financial Officer & General Counsel\n\n \n\n \n\n4"}